Homeopathy for Covid-19 in Primary Care: A structured summary of a study protocol for a randomized controlled trial.

ABSTRACT:

Objectives

To investigate the effectiveness and safety of homeopathic medicine Natrum muriaticum (LM2) for mild cases of COVID-19 in Primary Health Care.

Trial design

A randomized, two-armed (1:1), parallel, placebo-controlled, double-blind, clinical trial is being performed to test the following hypotheses: H0: homeopathic medicines = placebo (null hypothesis) vs. H1: homeopathic medicines ≠ placebo (alternative hypothesis) for mild cases of COVID-19 in Primary Care.

Participants

Setting: Primary Care of São Carlos - São Paulo - Brazil. One hundred participants aged 18 years or older, with Influenza-like symptoms and a positive RT-PCR for SARS-CoV-2. Willingness to give informed consent and to comply with the study procedures is also required. Exclusion criterium: se

SUBMITTER: Adler UC 

PROVIDER: S-EPMC7848248 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature